Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP, Population immunity against COVID-19 in the United States, Annals of Internal Medicine 2021, 174(11):1586-1591.
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer BH, McDonald RH, Fitzpatrick MC, Galvani AP, Optimizing COVID-19 quarantine and testing strategies, Nature Communications 2021, 21: 356.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Shoukat A, Bawden CE, Röst G, LeBlanc JJ, Galvani AP, Langley JM, Moghadas SM, Impact and cost-Effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study, Vaccine 2024, 7: 1768-1776.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP, Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States, Clinical Infectious Diseases 2023: 78: 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM,Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Xu J, Wang Z, Moghadas SM, Modelling the effect of travel-related policies on disease control in a meta-population structure, Journal of Mathematical Biology 2023, 87: 55.
Pandey A, Fitzpatrick MC, Moghadas SM, Vilches TN, Ko C, Vasan A, Galvani AP, Modelling a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City, The Lancet Regional Health - Americas 2023, 24: 100555.
Li A, Wu J, Moghadas SM, Epidemic dynamics with time-varying transmission risk reveal the role of disease stage-dependent infectiousness, Journal of Theoretical Biology 2023, 573: 111594.
Fitzpatrick MC, Moghadas SM, Vilches TN, Shah A, Pandey A, Galvani AP, Estimated US pediatric hospitalizations and school absenteeism associated with accelerated COVID-19 bivalent booster vaccination, JAMA Network Open 2023, 6(5): e2313586.
Pandey A, Wells CR, Stadnytskyi V, Sah P, Moghadas SM, Marathe M, Singer BH, Nesterova O, Galvani AP, Disease burden among Ukrainians forcibly displaced by the 2022 Russian invasion, Proceedings of the National Academy of Sciences USA 2023, 120(8): e2215424120.
Shi C, Vilches TN, Li A, Wu J, Moghadas SM, Modelling mutation-driven emergence of drug-resistance: a case study of SARS-CoV-2, Book Chapter, Springer 2023, 161–174.
Li A, Wang Z, Moghadas SM, Modelling the impact of timelines of testing and isolation on disease control, Infectious Disease Modelling 2023, 8: 58–71.